Oral Small-Molecule Elecoglipron Tackles Obesity and Diabetes
NEW ORLEANS — Treatment with investigational elecoglipron led to weight loss in people with obesity and improved glucose control in those with type 2 diabetes, a pair of global phase…
Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD
NEW ORLEANS — Treatment with survodutide led to significant weight loss and reductions in liver fat in phase III trials of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), but…
Obesity With a Normal BMI? Study Suggests It’s Common
Over 26% of U.S. adults with a normal BMI met new criteria for clinical obesity proposed by the Lancet commission. About 78% of adults had excess adiposity if defined by…
Trump’s Doc Says President Is in ‘Excellent Health’ as BMI Approaches Obesity Range
Donald Trump’s physician says the president is in “excellent health” and is “fully fit” to serve as commander in chief after a medical exam Tuesday at Walter Reed National Military…
